Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dale N Gerding

Showing results (61-70 of 199) with videos related to

Pageof 20
Sort By:
The Journal of Infectious Diseases|November 26, 2002
Colonization for the prevention of Clostridium difficile disease in hamstersSusan P Sambol, Michelle M Merrigan, Janet K Tang, et al.
Frontiers in Microbiology|January 7, 2022
Host Immune Responses to <i>Clostridioides difficile</i>: Toxins and BeyondBritt Nibbering, Dale N Gerding, Ed J Kuijper, et al.
Anaerobe|August 25, 2009
Rifaximin Redux: treatment of recurrent Clostridium difficile infections with rifaximin immediately post-vancomycin treatmentStuart Johnson, Christopher Schriever, Ursula Patel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 19, 2005
A hospital outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genesM Catherine McEllistrem, Robert J Carman, Dale N Gerding, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2012
Sustained clinical response as an endpoint in treatment trials of Clostridium difficile-associated diarrheaStuart Johnson, Dale N Gerding, Thomas J Louie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2018
Results From a Randomized, Placebo-Controlled Clinical Trial of a RBX2660-A Microbiota-Based Drug for the Prevention of Recurrent Clostridium difficile InfectionErik R Dubberke, Christine H Lee, Robert Orenstein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 26, 2014
Lack of evidence for an unmet need to treat Clostridium difficile infection in infants aged <2 years: expert recommendations on how to address this issueSaul N Faust, Mark H Wilcox, Aleksandra Banaszkiewicz, et al.
The Journal of Infectious Diseases|January 15, 2008
Infection of hamsters with historical and epidemic BI types of Clostridium difficileNadia Razaq, Susan Sambol, Kristin Nagaro, et al.
The Journal of Pediatrics|May 24, 2015
Risk Factors for Recurrent Clostridium difficile Infection in Children: A Nested Case-Control StudyLarry K Kociolek, Hannah L Palac, Sameer J Patel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 8, 2017
Vancomycin Taper and Pulse Regimen With Careful Follow-up for Patients With Recurrent Clostridium difficile InfectionBenjamin D Sirbu, Melinda M Soriano, Carl Manzo, et al.
Pageof 20

Showing results (61-70 of 199) with videos related to

Sort By:
Pageof 20
The Journal of Infectious Diseases|November 26, 2002
Colonization for the prevention of Clostridium difficile disease in hamstersSusan P Sambol, Michelle M Merrigan, Janet K Tang, et al.
Frontiers in Microbiology|January 7, 2022
Host Immune Responses to <i>Clostridioides difficile</i>: Toxins and BeyondBritt Nibbering, Dale N Gerding, Ed J Kuijper, et al.
Anaerobe|August 25, 2009
Rifaximin Redux: treatment of recurrent Clostridium difficile infections with rifaximin immediately post-vancomycin treatmentStuart Johnson, Christopher Schriever, Ursula Patel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 19, 2005
A hospital outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genesM Catherine McEllistrem, Robert J Carman, Dale N Gerding, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2012
Sustained clinical response as an endpoint in treatment trials of Clostridium difficile-associated diarrheaStuart Johnson, Dale N Gerding, Thomas J Louie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2018
Results From a Randomized, Placebo-Controlled Clinical Trial of a RBX2660-A Microbiota-Based Drug for the Prevention of Recurrent Clostridium difficile InfectionErik R Dubberke, Christine H Lee, Robert Orenstein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 26, 2014
Lack of evidence for an unmet need to treat Clostridium difficile infection in infants aged <2 years: expert recommendations on how to address this issueSaul N Faust, Mark H Wilcox, Aleksandra Banaszkiewicz, et al.
The Journal of Infectious Diseases|January 15, 2008
Infection of hamsters with historical and epidemic BI types of Clostridium difficileNadia Razaq, Susan Sambol, Kristin Nagaro, et al.
The Journal of Pediatrics|May 24, 2015
Risk Factors for Recurrent Clostridium difficile Infection in Children: A Nested Case-Control StudyLarry K Kociolek, Hannah L Palac, Sameer J Patel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 8, 2017
Vancomycin Taper and Pulse Regimen With Careful Follow-up for Patients With Recurrent Clostridium difficile InfectionBenjamin D Sirbu, Melinda M Soriano, Carl Manzo, et al.
Pageof 20